Update Recurrent Respiratory Papillomatosis 2023 (2023 AMW)
2023 AAO-HNSF Annual Meeting & OTO Experience
Recurrent Respiratory Papillomatosis (RRP) remains a problematic and challenging disease to manage for children, adolescents and adults. Newer, more refined and multi-modality surgical approaches assist in the successful treatment of the airway disease and enhance voice preservation. This course will discuss the use of these multi-modality approaches including the newer "blue laser" as well as microdebrider, coblation and simple cup forceps for surgical debulking. The role of biopsy and typing will be addressed. The increasingly important role of Gardasil preventative vaccination will be reviewed. The use of adjuvant medication has taken on an increasingly important role in achieving durable remission. Adjuvant intralesional and systemic injection therapies including Cidofovir and Bevacizumab, as well as "alternative" therapies will be closely examined. Critical issues such as timing for initiation of adjuvant therapies (a philosophic departure from traditional thought) and intervals and dosing as well as voice, psychosocial and family concerns will be presented. Up to date research advances in therapeutic DNA vaccines and check point inhibitors will be discussed.
Credits
CME:1.0, MOC:1.0